BIOLASE (NASDAQ:BIOL) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a report issued on Friday morning. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Stock Performance

Shares of NASDAQ:BIOL opened at $0.01 on Friday. BIOLASE has a 52 week low of $0.02 and a 52 week high of $1.94. The firm has a market cap of $260,574.60, a PE ratio of 0.00 and a beta of 0.67. The firm’s fifty day moving average is $0.01 and its 200-day moving average is $0.01.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.